🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Experimental Drug Acquiring Popularity Online

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these profiles directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with numerous of participants share comparison images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Some professionals said the popularity for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, advertising, and customer regulations, risking fines, legal action or prison.

Service Reaction and Content Elimination

Based on TikTok, the platform has taken down violative material and banned associated keywords and search suggestions. The company stated it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also discovered groups with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, glowing reviews and detailed instructions for mixing or injecting at home.

After moments of joining one community, a vendor posted contact information, where most purchases take place. The seller provided an instruction manual and guaranteed shipping within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Item Details and Pricing

Inside these communities, messages show black plastic packages with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service stated it regularly monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already seen individuals injured by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to potentially significant medical dangers”.